| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.459 | 17.537 | 23.470 | 23.114 | 46.515 | 20.111 | 19.663 | 14.791 | 13.445 | 13.243 |
| Total Income - EUR | 14.589 | 17.608 | 23.496 | 23.184 | 47.084 | 20.728 | 19.672 | 14.795 | 13.457 | 13.375 |
| Total Expenses - EUR | 15.926 | 10.094 | 16.740 | 16.947 | 21.780 | 19.957 | 9.102 | 18.105 | 25.956 | 11.153 |
| Gross Profit/Loss - EUR | -1.337 | 7.514 | 6.755 | 6.237 | 25.304 | 772 | 10.570 | -3.310 | -12.499 | 2.222 |
| Net Profit/Loss - EUR | -1.775 | 7.050 | 6.519 | 6.015 | 24.854 | 621 | 10.105 | -3.691 | -12.633 | 1.848 |
| Employees | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ina Biomarket S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 489 | 1.963 | 1.763 | 1.347 | 7.929 | 5.920 | 4.132 | 1.893 | 0 | 0 |
| Current Assets | 459 | 2.276 | 4.281 | 559 | 19.050 | 21.882 | 32.044 | 10.580 | 3.683 | 1.550 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 90 | 940 | 91 | 78 | 110 | 133 | 0 | 0 | 35 | 306 |
| Cash | 369 | 1.336 | 4.190 | 480 | 18.940 | 21.749 | 32.044 | 10.580 | 3.647 | 1.245 |
| Shareholders Funds | -18.489 | -11.251 | -4.541 | 1.557 | 26.381 | 26.502 | 36.019 | 12.162 | -508 | 1.344 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 0 |
| Debts | 19.436 | 15.489 | 10.586 | 349 | 598 | 1.300 | 158 | 311 | 4.190 | 207 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Ina Biomarket S.r.l.